Literature DB >> 18614620

Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury.

Michael M Yeboah1, Xiangying Xue, Mohammad Javdan, Myron Susin, Christine N Metz.   

Abstract

The cholinergic anti-inflammatory pathway is a mechanism whereby local inflammation is modulated by the brain via the vagus nerve and nicotinic acetylcholine receptors (nAChRs). The nAChR family are ligand-gated ion channels that consist of many different subtypes formed by the specific assembly of five polypeptide subunits including alpha1-10, beta1-4, gamma, delta, and epsilon. The alpha7 receptor (alpha7nAChR) mediates the anti-inflammatory effects of cholinergic stimulation. We recently demonstrated that cholinergic agonists attenuate renal ischemia-reperfusion (I/R) injury in rats. We also showed that tubular epithelial cells express functional nAChRs in vitro. The current studies report the expression, localization, and regulation of the alpha7nAChR in the rat kidney after I/R injury. We also examined, in this model, potential interactions between cholinergic stimulation and the STAT3 pathway, a key signaling cascade that has been linked to alpha7nAChR activation. RT-PCR and immunohistochemistry showed constitutive expression of many nAChR subunits. Immunohistochemistry localized basal alpha7nAChR expression to the endothelium of cortical peritubular capillaries, and its distribution was upregulated after I/R injury. Western blotting also showed an increase in alpha7nAChR subunit protein after renal I/R injury. Interestingly, pretreatment with nicotine, which improves the outcome after renal I/R injury, reduced the alpha7nAChR protein after I/R injury. Finally, we found that I/R injury stimulated the STAT3 pathway, whereas pretreatment with nicotine downregulated its activation. These results suggest that the alpha7nAChR plays an important role in the pathophysiology of renal I/R injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614620      PMCID: PMC2536882          DOI: 10.1152/ajprenal.90255.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  38 in total

1.  Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat.

Authors:  Niansheng Yang; Mingqian Luo; Rong Li; Yuefang Huang; Rui Zhang; Qingqing Wu; Fang Wang; Youji Li; Xueqing Yu
Journal:  Nephrol Dial Transplant       Date:  2007-07-31       Impact factor: 5.992

2.  Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats.

Authors:  Minoru Fujiki; Hidenori Kobayashi; Susumu Uchida; Ryo Inoue; Keisuke Ishii
Journal:  Brain Res       Date:  2005-05-10       Impact factor: 3.252

Review 3.  Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2005-11-16       Impact factor: 10.121

4.  Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations.

Authors:  Saul R Powell; Kelvin J A Davies; Andras Divald
Journal:  J Mol Cell Cardiol       Date:  2006-11-30       Impact factor: 5.000

5.  Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.

Authors:  Valentin A Pavlov; Mahendar Ochani; Li-Hong Yang; Margot Gallowitsch-Puerta; Kanta Ochani; Xinchun Lin; Jelena Levi; William R Parrish; Mauricio Rosas-Ballina; Christopher J Czura; Gregory J Larosa; Edmund J Miller; Kevin J Tracey; Yousef Al-Abed
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

6.  T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response.

Authors:  Seddigheh Razani-Boroujerdi; R Thomas Boyd; Martha I Dávila-García; Jayashree S Nandi; Neerad C Mishra; Shashi P Singh; Juan Carlos Pena-Philippides; Raymond Langley; Mohan L Sopori
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

7.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

8.  Release of acetylcholine from isolated canine renal tissue.

Authors:  C J Pirola; A L Alvarez; S Finkielman; V E Nahmod
Journal:  Am J Physiol       Date:  1991-02

9.  Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock.

Authors:  Salvatore Guarini; Domenica Altavilla; Maria-Michela Cainazzo; Daniela Giuliani; Albertino Bigiani; Herbert Marini; Giovanni Squadrito; Letteria Minutoli; Alfio Bertolini; Rolando Marini; Elena B Adamo; Francesco S Venuti; Francesco Squadrito
Journal:  Circulation       Date:  2003-03-04       Impact factor: 39.918

10.  Protection of early phase hepatic ischemia-reperfusion injury by cholinergic agonists.

Authors:  Elahé T Crockett; James J Galligan; Bruce D Uhal; Jack Harkema; Robert Roth; Kinnari Pandya
Journal:  BMC Clin Pathol       Date:  2006-02-15
View more
  24 in total

1.  Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein.

Authors:  Kavin G Shah; Derry Rajan; Asha Jacob; Rongqian Wu; Kambhampaty Krishnasastry; Jeffrey Nicastro; Ernesto P Molmenti; Gene F Coppa; Ping Wang
Journal:  J Surg Res       Date:  2010-04-24       Impact factor: 2.192

2.  Estrogen dependence of the renal vasodilatory effect of nicotine in rats: role of α7 nicotinic cholinergic receptor/eNOS signaling.

Authors:  Mahmoud M el-Mas; Sahar M el-Gowilly; Eman Y Gohar; Abdel-Rheem M Ghazal; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2010-11-16       Impact factor: 5.037

3.  Chronic nicotine exposure exacerbates acute renal ischemic injury.

Authors:  Istvan Arany; Samira Grifoni; Jeb S Clark; Eva Csongradi; Christine Maric; Luis A Juncos
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

4.  Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway.

Authors:  Joseph C Gigliotti; Liping Huang; Hong Ye; Amandeep Bajwa; Kryt Chattrabhuti; Sangju Lee; Alexander L Klibanov; Kambiz Kalantari; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-08-01       Impact factor: 10.121

5.  "Smoker's Paradox" in Patients Treated for Severe Injuries: Lower Risk of Mortality After Trauma Observed in Current Smokers.

Authors:  Teresa M Bell; Demetria R Bayt; Ben L Zarzaur
Journal:  Nicotine Tob Res       Date:  2015-02-02       Impact factor: 4.244

Review 6.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

7.  Human ghrelin protects animals from renal ischemia-reperfusion injury through the vagus nerve.

Authors:  Derry Rajan; Rongqian Wu; Kavin G Shah; Asha Jacob; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2011-09-22       Impact factor: 3.982

8.  Nicotine increased VEGF and MMP2 levels in the rat eye and kidney.

Authors:  Mehmet Ates; Ferda Hosgorler; Oguz Yuksel; Sultan Kaya Unsal; Guven Guvendi; Asli Karakilic; Basar Koc; Sevim Kandis; Lutfiye Kanit; Nazan Uysal
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-02       Impact factor: 4.223

9.  Nicotinic acetylcholine receptor-mediated protection of the rat heart exposed to ischemia reperfusion.

Authors:  Spyros A Mavropoulos; Nayaab S Khan; Asaph C J Levy; Bradley T Faliks; Cristina P Sison; Valentin A Pavlov; Youhua Zhang; Kaie Ojamaa
Journal:  Mol Med       Date:  2017-06-08       Impact factor: 6.354

Review 10.  Nicotine signaling and progression of chronic kidney disease in smokers.

Authors:  Gaurav Jain; Edgar A Jaimes
Journal:  Biochem Pharmacol       Date:  2013-07-26       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.